scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q2 EPS of ($0.44), $0.03 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $8.05 million versus the consensus estimate of $8.09 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.